期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023; 67 ()
Cognitive impairments are evident in remitted patients with bipolar disorder (BD) and their unaffected relatives (UR) compared to healthy controls (HC......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023; 68 ()
Deep brain stimulation (DBS) has emerged as a neuromodulation therapy for treatment -resistant depression, but its actual efficacy and mechanisms of a......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023; 73 ()
The Transient Receptor Potential Vanilloid 1 (TRPV1) non-selective cation channel predomi-nantly expressed in primary sensory neurons of the dorsal ro......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023; 74 ()
Several studies performed on human subjects have examined the effects of adolescent cannabis consumption on brain structure or function using brain im......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023; 74 ()
Psilocybin is investigated as a fast-acting antidepressant used in conjunction with psychother-apy. Intact cognitive functions, including memory, are ......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023; 77 ()
Functional impairment is a common symptom in schizophrenia (SZ) and bipolar disorder (BD). Pharmacological treatments have limited functional recovery......
